title: Lipid-associated rheumatologic syndromes.
abstract: Rheumatologic manifestations of hyperlipidemia and lipid-associated arthritis are rarely seen in the rheumatologist's office. On the other hand, a rheumatologist may be the clinician who identifies and initiates proper therapy for disorders related to hyperlipidemia when the musculoskeletal manifestations of these syndromes are recognized. In this article both the joint and tendon manifestations are reviewed, including the lesser known lipid liquid crystal form of arthritis. The relationship between gout and hyperuricemia is briefly discussed, as are the autoimmune manifestations of lipid-lowering therapy.
authors.affiliation: Division of Rheumatology, University of Washington, Box 356428, Seattle, WA 98195, USA.
authors.forename: Eyal
authors.initials: E
authors.lastname: Kedar
authors.forename: Gregory C
authors.initials: GC
authors.lastname: Gardner
mesh_terms: D001168:Arthritis / Q000150:complications* / Q000276:immunology / Q000378:metabolism; D001327:Autoimmune Diseases / Q000150:complications / Q000276:immunology / Q000378:metabolism; D006073:Gout / Q000150:complications / Q000276:immunology / Q000378:metabolism; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000150:complications* / Q000276:immunology / Q000378:metabolism; D006952:Hyperlipoproteinemia Type III / Q000150:complications* / Q000276:immunology / Q000378:metabolism; D033461:Hyperuricemia / Q000150:complications / Q000276:immunology / Q000378:metabolism; D050356:Lipid Metabolism; D013710:Tendons; D014973:Xanthomatosis / Q000150:complications* / Q000276:immunology / Q000378:metabolism